Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Virol J ; 20(1): 277, 2023 Nov 28.
Article in English | MEDLINE | ID: mdl-38017515

ABSTRACT

BACKGROUND: In a randomized trial, Lianhuaqingwen (LHQW) capsule was effective for accelerating symptom recovery among patients with coronavirus disease 2019 (COVID-19). However, the lack of blinding and limited sample sizes decreased the level of clinical evidence. OBJECTIVES: To evaluate the efficacy and safety of LHQW capsule in adults with mild-to-moderate COVID-19. METHODS: We conducted a double-blind randomized controlled trial in adults with mild-to-moderate COVID-19 (17 sites from China, Thailand, Philippine and Vietnam). Patients received standard-of-care alone or plus LHQW capsules (4 capsules, thrice daily) for 14 days. The primary endpoint was the median time to sustained clinical improvement or resolution of nine major symptoms. RESULTS: The full-analysis set consisted of 410 patients in LHQW capsules and 405 in placebo group. LHQW significantly shortened the primary endpoint in the full-analysis set (4.0 vs. 6.7 days, hazards ratio: 1.63, 95% confidence interval: 1.39-1.90). LHQW capsules shortened the median time to sustained clinical improvement or resolution of stuffy or runny nose (2.8 vs. 3.7 days), sore throat (2.0 vs. 2.6 days), cough (3.2 vs. 4.9 days), feeling hot or feverish (1.0 vs. 1.3 days), low energy or tiredness (1.3 vs. 1.9 days), and myalgia (1.5 vs. 2.0 days). The duration to sustained clinical improvement or resolution of shortness of breath, headache, and chills or shivering did not differ significantly between the two groups. Safety was comparable between the two groups. No serious adverse events were reported. INTERPRETATION: LHQW capsules promote recovery of mild-to-moderate COVID-19 via accelerating symptom resolution and were well tolerated. Trial registration ChiCTR2200056727 .


Subject(s)
COVID-19 , Drugs, Chinese Herbal , Adult , Humans , Double-Blind Method , Drugs, Chinese Herbal/therapeutic use , Treatment Outcome
2.
Molecules ; 25(3)2020 Feb 01.
Article in English | MEDLINE | ID: mdl-32024194

ABSTRACT

Owing to its unique structure and properties, the glucose dendrimer phytoglycogen is gaining interest for medical and biotechnology applications. Although many maize variants are available from commercial and academic breeding programs, most applications rely on phytoglycogen extracted from the common maize variant, sugary1. Here we characterized the solubility, hydrodynamic diameter, water-binding properties, protein contaminant concentration, and cytotoxicity of phytoglycogens from different maize sources, A632su1, A619su1, Wesu7, and Ia453su1, harboring various sugary1 mutants. A619su1-SW phytoglycogen was cytotoxic while A632su1-SW phytoglycogen was not. A632su1-Pu phytoglycogen promoted cell growth, whereas extracts from A632su1-NE, A632su1-NC, and A632su1-CM were cytotoxic. Phytoglycogen extracted from Wesu7su1-NE using ethanol precipitation was cytotoxic. Acid-treatment improved Wesu7 phytoglycogen cytocompatibility. Protease-treated Wesu7 extracts promoted cell growth. Phytoglycogen extracted from Ia453su1 21 days after pollination ("Ia435su1 21DAP") was cytotoxic, whereas phytoglycogen extracted at 40 days ("Ia435su1 40DAP") was not. In general, size and solubility had no correlation with cytocompatibility, whereas protein contaminant concentration and water-binding properties did. A632su1-CM had the highest protein contamination among A632 mutants, consistent with its higher cytotoxicity. Likewise, Ia435su1 21DAP phytoglycogen had higher protein contamination than Ia435su1 40DAP. Conversely, protease-treated Wesu7 extracts had lower protein contamination than the other Wesu7 extracts. A632su1-NE, A632su1-NC, and A632su1-CM had similar water-binding properties which differed from those of A632su1-Pu and A632su1-SW. Likewise, water binding differed between Ia435su1 21DAP and Ia435su1 40DAP. Collectively, these data demonstrate that maize phytoglycogen extracts are not uniformly cytocompatible. Rather, maize variant, plant genotype, protein contaminants, and water-binding properties are determinants of phytoglycogen cytotoxicity.


Subject(s)
Chemical Phenomena , Glycogen/chemistry , Phytochemicals/chemistry , Plant Extracts/chemistry , Zea mays/chemistry , Animals , Cell Survival/drug effects , Glycogen/pharmacology , Hydrodynamics , Mice , Molecular Structure , NIH 3T3 Cells , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Solubility , Spectrum Analysis
3.
Biomed Pharmacother ; 121: 109668, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31766103

ABSTRACT

Velvet antler is one of the most important animal medicines or functional foods widely used in East Asia for many centuries, which has several biological activities including anti-ageing and health promotion. To date, the mechanism underlying these effects of velvet antler is widely studied by its protein or polypeptide components. Few studies have been reported for the function of the other components in velvet antler. Herein, C. elegans is used as the model animal to dissect how none protein components of velvet antler affect in vivo oxidative stress. Methanol extracts (MEs) from velvet antler which has few protein components extends the maximum lifespan of C. elegans compared to the control under oxidative stress, while water extracts (WEs) which is protein-rich component has no apparent function. The activity of MEs is mediated by clk-1 signaling pathway, but not via daf-2, eat-2 or glp-1 pathway. Further investigations show MEs decrease endogenous ROS by promoting SKN-1 nuclei translocation, subsequently up-regulating the expression of its target genes gst-4, gst-7 and gst-10 in C. elegans. In all, MEs, the none protein components of velvet antler, protects against oxidative stress in C. elegans, which indicates it might be a product with potential of being a curative medicine.


Subject(s)
Antlers/chemistry , Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/drug effects , DNA-Binding Proteins/metabolism , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Protective Agents/pharmacology , Transcription Factors/metabolism , Animals , Caenorhabditis elegans/metabolism , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Longevity/drug effects , Methanol/chemistry , Plant Extracts/chemistry , Protective Agents/chemistry , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Up-Regulation/drug effects
4.
Spectrochim Acta A Mol Biomol Spectrosc ; 211: 299-305, 2019 Mar 15.
Article in English | MEDLINE | ID: mdl-30562703

ABSTRACT

A novel fluorescence probe L2 based on coumarin has been designed and synthesized. The probe L2 can be used for relay recognition of metal ions Al3+ and anion F- in the aqueous HEPES buffer (0.05 M, pH = 7.4), and build a OFF-ON-OFF detection system. The probe showed high selectivity and sensitivity to target ions in the process of relay recognition, and the corresponding detection limit could be as low as 0.014 µM (Al3+) and 0.03 µM (F-). Besides, the geometry optimizations of probe L2 and [L2 + Al3+] complex were carried out using the Gaussian 16 program based on DFT, and the identification mechanism of the probe was also discussed by the mass spectrometry and theoretical calculations. Moreover, the probe has also been successfully applied to detection of target ions in living cells.


Subject(s)
Aluminum/analysis , Fluorescent Dyes/chemistry , Fluorides/analysis , Molecular Imaging/methods , Aluminum/metabolism , Cell Line, Tumor , Coumarins/chemistry , Density Functional Theory , Fluorescent Dyes/chemical synthesis , Fluorescent Dyes/metabolism , HEPES , Humans , Hydrogen-Ion Concentration , Limit of Detection , Molecular Structure , Normal Distribution , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Tea/chemistry , Toothpastes/analysis
SELECTION OF CITATIONS
SEARCH DETAIL